ft 21 apr 93 uk compani news new drug help sb rise 12 pound 306m smithklin beecham anglo american drug consum product group yesterday report pre tax profit first quarter march 31 ahead 12 per cent pound 272m pound 306m sale 26 per cent greater pound 1 52bn compar pound 1 21bn result aid currenc compar exchang rate sale 11 per cent pre tax profit 10 per cent compani said profit less affect currenc hedg polici earn per share 14 per cent 6 6p 7 5p mr bob bauman chief execut said four year substanti growth sb right track ongo growth control healthcar cost prioriti govern leader understand medicin account less 10 per cent total medic cost countri dramat lower cost maintain health limit need far expens surgeri hospitalis said europ pharmaceut sale grew 3 per cent legisl itali germani cut sale 15 per cent 11 per cent respect uk franc rose 10 per cent 19 per cent pharmaceut divis turnov rose 32 per cent pound 674m pound 886m trade profit increas 14 per cent pound 215m pound 245m perform help us sale 25 per cent drug sale also help new product come stream fulli period last year sale new product pound 95m compar pound 212m 1992 includ seroxat anti depress known paxil us relafen anti arthrit kytril anti nausea vomit treatment havrix hepat vaccin sale augmentin antibiot increas 22 per cent pound 212m follow weak first quarter last year sale tagamet anti ulcer compound tradit compani best sell drug fell 22 per cent unusu strong first quarter 1992 medicin come patent next month us largest market consum brand includ lucazad ribena gener turnov 10 per cent pound 322m pound 355m oper profit fell 14 per cent pound 43m pound 37m first quarter dividend 2 533p per share 4 896 cent per equiti unit